2011
DOI: 10.1016/j.neuroscience.2011.05.062
|View full text |Cite
|
Sign up to set email alerts
|

Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats

Abstract: In this project, we examined peripheral δ-opioid receptor (DOR)-mediated anti-hyperalgesic responses in the context of an acute orofacial muscle pain condition in both male and female rats. We also investigated whether the ATP-sensitive K+ channel (KATP), a downstream target of OR signaling, contributes to DOR-mediated anti-hyperalgesic responses. Local pretreatment of the masseter with a DOR agonist, DPDPE, dose-dependently attenuated capsaicin-induced mechanical hypersensitivity in both male and female rats.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
24
0
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 51 publications
2
24
0
1
Order By: Relevance
“…Consistent with these observations we have recently shown that capsaicin-induced masseter hypersensitivity is attenuated by direct activation of δ opioid receptors (DOR) in TG and that the DOR-mediated anti-hyperalgesic responses are reversed when KATP is blocked by a specific KATP antagonist, glibenclamide (Saloman et al, 2010). Interestingly, the DOR-mediated responses were significantly more potent in male compared to female rats.…”
Section: Discussionsupporting
confidence: 58%
“…Consistent with these observations we have recently shown that capsaicin-induced masseter hypersensitivity is attenuated by direct activation of δ opioid receptors (DOR) in TG and that the DOR-mediated anti-hyperalgesic responses are reversed when KATP is blocked by a specific KATP antagonist, glibenclamide (Saloman et al, 2010). Interestingly, the DOR-mediated responses were significantly more potent in male compared to female rats.…”
Section: Discussionsupporting
confidence: 58%
“…It is also important to note that pre-clinical studies demonstrating the effectiveness of peripheral opioid receptors are continuously being accumulated, even including those under neuropathic pain conditions (Shinoda et al, 2007; Guan et al, 2008; Sánchez et al, 2010; Saloman et al, 2011; Auh and Ro, 2012; Martins et al, 2012; Ni et al, 2013). Therefore, peripheral opioid receptors still remain as a viable target for pain management, especially under inflammatory conditions, and additional human experimental as well as clinical studies are definitely warranted.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, it is known that release of intracellular Ca +2 stores by Gq-coupled receptors activates CaMKII, which stimulates neuronal nitric oxide synthase and nitric oxide release leading to cGMP production and protein kinase G-mediated activation of K ATP channels; this then produces analgesia via hyperpolarization of primary afferents (Gong et al, 2015). A direct association of this cascade with antinociceptive actions of peripherally administered DOPr agonists is suggested by the fact by K ATP blockers, neuronal nitric oxide synthase inhibitors, and inactive cGMP analogs all interfere with DOPr-mediated analgesia (Pacheco and Duarte, 2005;Saloman et al, 2011;Gutierrez et al, 2012).…”
Section: D-opioid Receptors and Phospholipase Signalingmentioning
confidence: 99%